NovoCure
NVCR
NVCR
104 hedge funds and large institutions have $746M invested in NovoCure in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
22% more funds holding
Funds holding: 85 → 104 (+19)
5% more ownership
Funds ownership: 37.2% → 42.2% (+5%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
104
Holding in Top 10
4
Calls
$24.4M
Puts
$4.75M
Top Buyers
| 1 | +$18M | |
| 2 | +$13M | |
| 3 | +$11.1M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$8.92M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$8.9M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$4.4M | |
| 3 | -$4.34M | |
| 4 |
SG
StepStone Group
La Jolla,
California
|
-$3.97M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$3.2M |